These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27221934)

  • 1. Are Biomarkers Predictive of Anthracycline-Induced Cardiac Dysfunction?
    Malik A; Jeyaraj PA; Calton R; Uppal B; Negi P; Shankar A; Patil J; Mahajan MK
    Asian Pac J Cancer Prev; 2016; 17(4):2301-5. PubMed ID: 27221934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
    Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM
    Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
    Dodos F; Halbsguth T; Erdmann E; Hoppe UC
    Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
    Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
    Gulati G; Heck SL; Røsjø H; Ree AH; Hoffmann P; Hagve TA; Norseth J; Gravdehaug B; Steine K; Geisler J; Omland T
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29118031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
    Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
    Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevations in High-Sensitive Cardiac Troponin T and N-Terminal Prohormone Brain Natriuretic Peptide Levels in the Serum Can Predict the Development of Anthracycline-Induced Cardiomyopathy.
    Bisoc A; Ciurescu D; Rădoi M; Tântu MM; Rogozea L; Sweidan AJ; Bota DA
    Am J Ther; 2020; 27(2):e142-e150. PubMed ID: 30648987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
    Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
    Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
    Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
    Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
    Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
    Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients.
    Satyan S; Light RP; Agarwal R
    Am J Kidney Dis; 2007 Dec; 50(6):1009-19. PubMed ID: 18037101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.
    Roziakova L; Bojtarova E; Mistrik M; Dubrava J; Gergel J; Lenkova N; Mladosievicova B
    J Exp Clin Cancer Res; 2012 Feb; 31(1):13. PubMed ID: 22321767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity.
    Kilickap S; Barista I; Akgul E; Aytemir K; Aksoyek S; Aksoy S; Celik I; Kes S; Tekuzman G
    Ann Oncol; 2005 May; 16(5):798-804. PubMed ID: 15774486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.
    Frères P; Bouznad N; Servais L; Josse C; Wenric S; Poncin A; Thiry J; Moonen M; Oury C; Lancellotti P; Bours V; Jerusalem G
    BMC Cancer; 2018 Jan; 18(1):102. PubMed ID: 29378531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines.
    Pourier MS; Kapusta L; van Gennip A; Bökkerink JP; Loonen J; Bellersen L; Mavinkurve-Groothuis AM
    Clin Chim Acta; 2015 Feb; 441():29-32. PubMed ID: 25512165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.